Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87,965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Chen SY, Yang Y, Qi SN, Wang Y, Hu C, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Yuan ZY, Yahalom J, Tsang R, Song YQ, Zhu J, Su H, Li YX. Chen SY, et al. Leukemia. 2021 Jan;35(1):130-142. doi: 10.1038/s41375-020-0791-3. Epub 2020 Mar 9. Leukemia. 2021. PMID: 32152465 Free PMC article.
Radiotherapy plays an important role in improving the survival outcome in patients with T1-2N1M0 breast cancer - a joint analysis of 4262 real world cases from two institutions.
Sun GY, Wen G, Zhang YJ, Tang Y, Jing H, Wang JY, Zhang JH, Yang Y, Zhao XR, Chen SY, Jin J, Song YW, Liu YP, Fang H, Ren H, Tang Y, Qi SN, Li N, Chen B, Lu NN, Wang SL, Li YX. Sun GY, et al. BMC Cancer. 2020 Nov 26;20(1):1155. doi: 10.1186/s12885-020-07646-y. BMC Cancer. 2020. PMID: 33243177 Free PMC article.
Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy.
Sun GY, Jing H, Wang SL, Song YW, Jin J, Fang H, Liu YP, Ren H, Tang Y, Zhao XR, Song YC, Chen SY, Yang ZB, Chen B, Tang Y, Li N, Lu NN, Qi SN, Yang Y, Li YX. Sun GY, et al. Front Oncol. 2021 Jan 26;10:605750. doi: 10.3389/fonc.2020.605750. eCollection 2020. Front Oncol. 2021. PMID: 33575216 Free PMC article.
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015).
Wu Y, Liu X, Imber BS, Zhong QZ, Yang Y, Wu T, Chen SY, Chen B, Song YW, Fang H, Jin J, Liu YP, Jing H, Tang Y, Li N, Lu NN, Wang SL, Chen F, Yin L, Zhang XM, Zhu J, Tsang RW, Yahalom J, Hu C, Men K, Deng M, Xia C, Li YX, Qi SN. Wu Y, et al. Among authors: chen b, chen sy, chen f. Radiother Oncol. 2022 Aug;173:179-187. doi: 10.1016/j.radonc.2022.05.034. Epub 2022 Jun 3. Radiother Oncol. 2022. PMID: 35667572
Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial.
Chen SY, Sun GY, Tang Y, Jing H, Song YW, Jin J, Liu YP, Zhao XR, Song YC, Chen B, Qi SN, Tang Y, Lu NN, Li N, Fang H, Li YX, Wang SL. Chen SY, et al. Eur J Cancer. 2022 Oct;174:153-164. doi: 10.1016/j.ejca.2022.07.023. Epub 2022 Aug 20. Eur J Cancer. 2022. PMID: 35998550 Free article. Clinical Trial.
Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions.
Sun GY, Wen G, Zhang YJ, Tang Y, Jing H, Fang H, Wang JY, Zhang JH, Zhao XR, Chen SY, Song YW, Jin J, Liu YP, Tang Y, Qi SN, Li N, Chen B, Lu NN, Li YX, Wang SL. Sun GY, et al. Front Oncol. 2022 Dec 20;12:955381. doi: 10.3389/fonc.2022.955381. eCollection 2022. Front Oncol. 2022. PMID: 36605447 Free PMC article.
87,965 results
You have reached the last available page of results. Please see the User Guide for more information.